For example, our recent study published in Nature in 2022 demonstrated that CCL4+ TAN promotes tumor growth by recruiting tumor-associated macrophages, whereas PD-L1+ TANs promote tumor growth by inhibiting the killing function of CD8+ T cells24. This evidence concerns the gene CD8A and neoplasm.